The Orange Pill Podcast

Episode 10: Update of Kennedy Reform of FDA Operations

In this episode of the Orange Pill Podcast, we explore the evolving landscape of federal health agencies under the leadership of Secretary Robert Kennedy Jr. We’ll take a closer look at the potential reforms he aims to implement at the FDA and how these changes could impact the industry.
From Kennedy's well-documented policy positions to recent initiatives by the Trump administration and the latest developments at HHS, we’re unpacking it all. 

Episode 9: The Science of Brain Supplements - Part 2

In this episode of The Orange Pill Podcast, we continue our deep dive into cognitive health, exploring the science behind brain supplements and how they support memory, focus, and overall mental clarity.
Tune in now for expert insights and practical takeaways!

Episode 8: Supplements for Brain Health - Part 1

In this episode, we dive into groundbreaking research on cognitive health, exploring a clinical study conducted at KGK Science on Neuriva, a leading brain health supplement. Learn how it impacts cognitive performance in healthy adults with self-perceived memory concerns—delivering insights you won’t want to miss!
Tune in for the science, and what it means for your brain health.

Episode 7: Exploring The Science, Benefits, Challenges and Regulatory Implications of GLP-1 Agonists as Functional Food Ingredients

In this episode, we unravel the fascinating world of GLP-1 agonists—widely known for their role in diabetes and weight management—and their potential as functional food ingredients. From scientific breakthroughs to real-world applications and regulatory hurdles, this discussion offers a comprehensive look at what the future may hold for these powerful metabolic modulators.

Episode 6: Science of Plant-Based Protein (Pea Protein vs Whey)

Could plant-based protein be just as effective as whey for muscle growth? In this episode, we break down a clinical trial conducted by KGK Science for Roquette, comparing pea protein and whey protein head-to-head. We discuss the findings, what they mean for athletes and fitness enthusiasts, and whether plant-based proteins are ready to take over the supplement industry.

Episode 5: The Science of Collagen Supplements

In Episode 5, we explore the science behind collagen supplements, including a KGK Science clinical trial on marine collagen from Vinh Wellness, published in the Journal of Cosmetic Dermatology. Tune in to discover what the research says about collagen’s impact on skin hydration, elasticity, and wrinkle reduction—and whether your supplement is really doing what it claims!

Episode 4: How Dietary Supplements Became Regulated - Part 3

In this episode, we continue our deep dive into the evolution of dietary supplement regulations. From the passage of DSHEA in 1994 to the introduction of cGMPs, health claim requirements, and the enforcement actions that shaped the industry, we explore how FDA oversight has developed over the years. We also discuss pivotal legal cases, the impact of the Bioterrorism Act, and the increasing role of clinical trials in substantiating supplement claims.

Episode 3: How Dietary Supplements Became Regulated - Part 2

In Part 2 of "How Supplements Became Regulated in the US" on the Orange Pill Podcast, the focus is on the Dietary Supplement Health and Education Act (DSHEA) of 1994, led by Senators Orrin Hatch and Tom Harkin. This legislation established the framework for dietary supplements, defining ingredients and directing the FDA to create NDI Guidance and GMP regulations. In Part 3, we will delve into federal legislation and rules that enhanced FDA compliance enforcement in the dietary supplement industry.

Episode 2: How Dietary Supplements Became Regulated - Part 1

Many believe dietary supplements aren't regulated, but they are. This podcast's Part I explores the history of their regulation in the US, from the 1960s Vitamin and Mineral Regulations to the NLEA of 1990 for labeling and the 1994 Dietary Supplement Health and Education Act. Stay tuned for future episodes detailing this fascinating journey.

Episode 1: The Trump Administration and the Future of the FDA

In this episode, we explore Robert F. Kennedy Jr.'s nomination as U.S. Secretary of Health and Human Services (HHS) and Elon Musk's leadership of the new Department of Government Efficiency (DOGE). We discuss potential budget cuts, workforce reductions, and regulatory changes within HHS and the FDA, particularly the Center for Food Safety and Applied Nutrition (CFSAN). Join us to speculate on the future of food additive regulations, the GRAS pathway, and government transparency.